Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors: Akira Iwanami, Kazuhiko Saito, Masakazu Fujiwara, Daiki Okutsu, Hironobu Ichikawa
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Psychiatry
Online Access:https://doi.org/10.1186/s12888-020-02965-7
id doaj-737b3822e2404ef1a4ad64cbad90187b
record_format Article
spelling doaj-737b3822e2404ef1a4ad64cbad90187b2020-12-27T12:19:32ZengBMCBMC Psychiatry1471-244X2020-12-012011410.1186/s12888-020-02965-7Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension studyAkira Iwanami0Kazuhiko Saito1Masakazu Fujiwara2Daiki Okutsu3Hironobu Ichikawa4Department of Psychiatry, Showa University School of MedicineAiiku Counselling Office, Aiiku Research Institute, Imperial Gift Foundation Boshi-Aiiku-KaiBiostatistics Center, Shionogi & Co., Ltd.Clinical Research Department, Shionogi & Co., LtdJapan Developmental Disorders NetworkAn amendment to this paper has been published and can be accessed via the original article.https://doi.org/10.1186/s12888-020-02965-7
collection DOAJ
language English
format Article
sources DOAJ
author Akira Iwanami
Kazuhiko Saito
Masakazu Fujiwara
Daiki Okutsu
Hironobu Ichikawa
spellingShingle Akira Iwanami
Kazuhiko Saito
Masakazu Fujiwara
Daiki Okutsu
Hironobu Ichikawa
Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
BMC Psychiatry
author_facet Akira Iwanami
Kazuhiko Saito
Masakazu Fujiwara
Daiki Okutsu
Hironobu Ichikawa
author_sort Akira Iwanami
title Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
title_short Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
title_full Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
title_fullStr Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
title_full_unstemmed Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
title_sort correction to: safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
publisher BMC
series BMC Psychiatry
issn 1471-244X
publishDate 2020-12-01
description An amendment to this paper has been published and can be accessed via the original article.
url https://doi.org/10.1186/s12888-020-02965-7
work_keys_str_mv AT akiraiwanami correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy
AT kazuhikosaito correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy
AT masakazufujiwara correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy
AT daikiokutsu correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy
AT hironobuichikawa correctiontosafetyandefficacyofguanfacineextendedreleaseinadultswithattentiondeficithyperactivitydisorderanopenlabellongtermphase3extensionstudy
_version_ 1724369171935920128